<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000334457">
  <TermName>edotecarin</TermName>
  <TermPronunciation>(eh-doh-TEH-kar-in)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is a type of topoisomerase I inhibitor. Also called J-107088.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731793" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;edotecarin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731792" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;edotecarina&quot;" language="es" id="_4"/>
  <SpanishTermName>edotecarina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor de la topoisomerasa. También se llama J-107088.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-09-24</DateFirstPublished>
  <DateLastModified>2007-07-06</DateLastModified>
</GlossaryTerm>
